Malcolm Francis Graham Stevens

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Cancer Research Technology Limited, Pharminox Limited. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Malcolm Francis Graham Stevens. Retrieved from https://idiyas.com/inventor/malcolm-francis-graham-stevens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 25.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Loughborough, GB (2013)
Nottingham, GB (2006 - 2015)

Company Filing History:

2 out of 269

Cancer Research Technology Limited

Years Active: 2006-2015

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9024018 - 3-substituted-8-substituted-3H-imidazo[5,1-d][1,2,3,5]tetrazin-4-one compounds and their use (2015-05-05),

2. 8450479 - 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5-tetrazine-8-carboxylic acid amides and their use (2013-05-28),

3. 7307099 - 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents (2007-12-11),

4. 7144893 - 4-aryl quinols and analogs thereof as therapeutic agents (2006-12-05),

Title: Malcolm Francis Graham Stevens: Innovator in Therapeutic Compounds

Introduction

Malcolm Francis Graham Stevens is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of therapeutic compounds, holding a total of four patents. His work primarily focuses on innovative compounds that have potential applications in treating proliferative disorders, including cancer.

Latest Patents

Stevens' latest patents include the development of 3-substituted-8-substituted-3H-imidazo[5,1-d][1,2,3,5]tetrazin-4-one compounds. This invention pertains to therapeutic compounds that can inhibit cell proliferation and treat various proliferative disorders. Another significant patent involves 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amides, which also focuses on similar therapeutic applications.

Career Highlights

Throughout his career, Stevens has worked with several companies, including Pharminox Limited and Cancer Research Technology Limited. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Some of his notable coworkers include David Cousin and Marc Geoffery Hummersone. Their collaboration has likely played a role in advancing the research and development of the compounds Stevens has patented.

Conclusion

Malcolm Francis Graham Stevens is a distinguished inventor whose work in therapeutic compounds has the potential to impact the treatment of serious health conditions. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.